This webinar aims to provide a summary of the use of natriuretic peptides (NP) in clinical practice, answering the following questions:
- What is the clinical use of measuring NP for diagnosis of heart failure (HF) in different settings, and how can the results be interpreted in the acute and chronic setting?
- What is the influence of sacubitril/valsartan on NP levels and should the interpretation of the values be changed?
- What are the characteristics and differences between the studies investigating therapy guidance by BNP and NT-proBNP and how should the study results be interpreted?
Presented by: Prof. dr. H.P. Brunner-La Rocca